MICHAEL G ATIEH
CIK 1072501 · EVP, CFO, & CBO, Treasurer · last filed 2026-05-26
MICHAEL G ATIEH is an EVP, CFO, & CBO, Treasurer who has filed 58 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for CB, was dated May 26, 2026. Across all open-market trades the lifetime net is −$7.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$13.13M
7
58
-$7.82M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CB | Director | 40,014 | $328.14 | $13.13M | -$2.38M | 22 | 2026-05-26 |
| Oyster Point Pharma, Inc. (OYST) Delisted | Director | 8,671 | $11.17 | $96.9K | $0 | 4 | 2023-01-04 |
| ECOR | Director | — | $10.25 | — | $0 | 3 | 2021-06-15 |
| IVERIC bio, Inc. (OPHT) Delisted | EVP, CFO, & CBO, Treasurer | 367 | — | — | -$9.4K | 3 | 2016-01-05 |
| Chubb Ltd (ACE) Delisted | Director | 38,618 | — | — | -$1.85M | 14 | 2015-05-26 |
| OSI PHARMACEUTICALS INC (OSIP) Delisted | Exec. VP & CFO | 32,447 | — | — | -$3.40M | 10 | 2008-12-16 |
| Chubb Ltd (ACEpC) Delisted | Director | 29,341 | — | — | -$185.7K | 2 | 2007-12-10 |
Recent Filings
58 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | CB | Mixed | −90 | -$254.2K | EDGAR |
| 2025-06-18 | CB | Sell (S) | −538 | -$154.7K | EDGAR |
| 2025-05-16 | CB | Mixed | +591 | -$52.6K | EDGAR |
| 2024-09-05 | CB | Sell (S) | −261 | -$75.0K | EDGAR |
| 2024-05-20 | CB | Sell (S) | −716 | -$193.1K | EDGAR |
| 2024-05-17 | CB | Mixed | +479 | -$63.3K | EDGAR |
| 2023-08-14 | CB | Sell (S) | −750 | -$156.3K | EDGAR |
| 2023-05-19 | CB | Mixed | +722 | -$46.4K | EDGAR |
| 2023-01-04 | Oyster Point Pharma, Inc. (OYST) Delisted | Mixed | −26,734 | $0 | EDGAR |
| 2022-06-08 | Oyster Point Pharma, Inc. (OYST) Delisted | Grant (A) | +3,573 | $0 | EDGAR |